[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:malignant-pleural-effusion":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":41,"states":42},"Malignant Pleural Effusion",5,4,[8,16,22,28,34],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07443020","Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:17:25.718160Z","2026-05-05T02:43:29.223994Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06016179","Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer",[12],"2026-08-26T02:18:02.701182Z","2026-05-05T02:43:28.549392Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07192900","Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease",[12],"2026-08-26T02:17:01.714035Z","2026-05-05T02:43:28.215725Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05620329","UNC Pleural Fluid Registry",[],"2026-08-26T02:19:06.150683Z","2026-05-13T02:55:06.364636Z",{"nct_id":35,"title":36,"phases":37,"status":38,"updated_at":39,"content_modified":40},"NCT02092155","Biomarker Levels During Indwelling Pleural cAtheter Sample Testing",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:20.225313Z","2026-06-16T05:54:07.948518Z",[],[43],{"state":44,"count":45,"slug":46},"Pennsylvania",3,"pennsylvania"]